The most probable reason is to understand whether stroma regulates/modulates p53 “with a normal function” in the context of drugs, as it is reported that at advanced stages of the disease (where the rate of p53 mutation will also increase) MM cells may become stroma-independent/unresponsive [77]. Here, TP53 is linked to Miyoshi myopathy.